Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1989 1
1990 1
1992 2
1993 1
1995 1
1999 1
2000 3
2002 4
2003 1
2004 2
2005 2
2006 3
2007 2
2008 2
2009 5
2010 4
2011 4
2012 3
2013 4
2014 7
2015 7
2016 2
2017 8
2018 7
2019 2
2020 10
2021 8
2022 7
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hereditary Adrenal Gland Pheochromocytoma"
Page 1
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, Söderkvist P, Stenman A, Larsson C, Svahn F, Chen JL, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, Hasse-Lazar K, Petersenn S, Moeller LC, Meyer A, Reisch N, Trupka A, Brase C, Galiano M, Preuss SF, Kwok P, Lendvai N, Berisha G, Makay Ö, Boedeker CC, Weryha G, Racz K, Januszewicz A, Walz MK, Gimm O, Opocher G, Eng C, Neumann HPH; European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group. Bausch B, et al. JAMA Oncol. 2017 Sep 1;3(9):1204-1212. doi: 10.1001/jamaoncol.2017.0223. JAMA Oncol. 2017. PMID: 28384794 Free PMC article.
MAX disease occurred almost exclusively in the adrenal glands with frequently bilateral tumors. Penetrance in the largest subset, SDHA carriers, was 39% at 40 years of age and is statistically different in index patients (45%) vs mutation-carrying relatives (13%; P …
MAX disease occurred almost exclusively in the adrenal glands with frequently bilateral tumors. Penetrance in the largest subs …
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
Fischer A, Kloos S, Maccio U, Friemel J, Remde H, Fassnacht M, Pamporaki C, Eisenhofer G, Timmers HJLM, Robledo M, Fliedner SMJ, Wang K, Maurer J, Reul A, Zitzmann K, Bechmann N, Žygienė G, Richter S, Hantel C, Vetter D, Lehmann K, Mohr H, Pellegata NS, Ullrich M, Pietzsch J, Ziegler CG, Bornstein SR, Kroiss M, Reincke M, Pacak K, Grossman AB, Beuschlein F, Nölting S. Fischer A, et al. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2676-2685. doi: 10.1210/clinem/dgad166. J Clin Endocrinol Metab. 2023. PMID: 36946182 Free PMC article.
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) with pathogenic mutations in the succinate dehydrogenase subunit B (SDHB) are associated with a high metastatic risk. ...Clinical data were extracted from medical records, and immunohistochemistry (IHC) for SDHB and SST …
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) with pathogenic mutations in the succinate dehydrogenase subunit B (SDHB) are a …
Hereditary and Sporadic Pheochromocytoma: Comparison of Imaging, Clinical, and Laboratory Features.
Chung R, O'Shea A, Sweeney AT, Mercaldo ND, McDermott S, Blake MA. Chung R, et al. AJR Am J Roentgenol. 2022 Jul;219(1):97-109. doi: 10.2214/AJR.21.26918. Epub 2022 Jan 26. AJR Am J Roentgenol. 2022. PMID: 35080458
Genetic testing was used to classify pheochromocytomas as hereditary or sporadic and to classify hereditary pheochromocytomas by germline mutation clusters. ...When combining CT and MRI, cystic change/necrosis was observed in 35% of hereditar …
Genetic testing was used to classify pheochromocytomas as hereditary or sporadic and to classify hereditary pheochro …
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.
Crona J, Taïeb D, Pacak K. Crona J, et al. Endocr Rev. 2017 Dec 1;38(6):489-515. doi: 10.1210/er.2017-00062. Endocr Rev. 2017. PMID: 28938417 Free PMC article. Review.
A molecular biology-based taxonomy has been proposed for pheochromocytoma and paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant prognostic and predictive biomarkers and stratified PPGLs into three main clusters. ...Here, we review …
A molecular biology-based taxonomy has been proposed for pheochromocytoma and paraganglioma (PPGL). Data from the Cancer Genome Atlas …
Update on Paragangliomas and Pheochromocytomas.
Lam AK. Lam AK. Turk Patoloji Derg. 2015;31 Suppl 1:105-12. doi: 10.5146/tjpath.2015.01318. Turk Patoloji Derg. 2015. PMID: 26177321 Free article. Review.
Pathological features, proliferative index, genetic and biochemical parameters could help to predict the malignant potential of paraganglioma and pheochromocytoma. Different predictive systems have been proposed and with the help of immunochemical studies. .. …
Pathological features, proliferative index, genetic and biochemical parameters could help to predict the malignant potential of parag …
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
Pamporaki C, Berends AMA, Filippatos A, Prodanov T, Meuter L, Prejbisz A, Beuschlein F, Fassnacht M, Timmers HJLM, Nölting S, Abhyankar K, Constantinescu G, Kunath C, de Haas RJ, Wang K, Remde H, Bornstein SR, Januszewicz A, Robledo M, Lenders JWM, Kerstens MN, Pacak K, Eisenhofer G. Pamporaki C, et al. Lancet Digit Health. 2023 Sep;5(9):e551-e559. doi: 10.1016/S2589-7500(23)00094-8. Epub 2023 Jul 18. Lancet Digit Health. 2023. PMID: 37474439 Free article.
BACKGROUND: Pheochromocytomas and paragangliomas have up to a 20% rate of metastatic disease that cannot be reliably predicted. ...INTERPRETATION: Although methoxytyramine has some utility for prediction of metastatic pheochromocytomas and paragangliom …
BACKGROUND: Pheochromocytomas and paragangliomas have up to a 20% rate of metastatic disease that cannot be reliably predicted …
The clinical genetics of phaeochromocytoma and paraganglioma.
Kavinga Gunawardane PT, Grossman A. Kavinga Gunawardane PT, et al. Arch Endocrinol Metab. 2017 Oct;61(5):490-500. doi: 10.1590/2359-3997000000299. Arch Endocrinol Metab. 2017. PMID: 29166454 Free PMC article. Review.
Phaeochromocytoma and paraganglioma are rare catecholamine-producing tumours, recognised to have one of the richest hereditary backgrounds of all neoplasms, with germline mutations seen in approximately 30% of patients. ...Apart from this, the genetic profile has im …
Phaeochromocytoma and paraganglioma are rare catecholamine-producing tumours, recognised to have one of the richest hereditary …
Update on pediatric pheochromocytoma.
Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K. Havekes B, et al. Pediatr Nephrol. 2009 May;24(5):943-50. doi: 10.1007/s00467-008-0888-9. Epub 2008 Jun 20. Pediatr Nephrol. 2009. PMID: 18566838 Review.
Pheochromocytomas are rare tumors in children arising from chromaffin cells of adrenal medullary or extra-adrenal paraganglionic tissue. ...In children, pheochromocytomas are more frequently familial, extra-adrenal, bilateral, and multifocal tha …
Pheochromocytomas are rare tumors in children arising from chromaffin cells of adrenal medullary or extra-adrenal parag …
Pathology and genetics of phaeochromocytoma and paraganglioma.
Turchini J, Cheung VKY, Tischler AS, De Krijger RR, Gill AJ. Turchini J, et al. Histopathology. 2018 Jan;72(1):97-105. doi: 10.1111/his.13402. Histopathology. 2018. PMID: 29239044 Review.
Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 per million. Advances in molecular understanding have led to the recognition that at least 30-40% arise in the setting of hereditary disease. Germline mutations i …
Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 per million. Advances in mole …
New therapeutic and surgical approaches for sporadic and hereditary pheochromocytoma.
Walther MM. Walther MM. Ann N Y Acad Sci. 2002 Sep;970:41-53. doi: 10.1111/j.1749-6632.2002.tb04411.x. Ann N Y Acad Sci. 2002. PMID: 12381540 Review.
The last decade has seen the identification of the genes responsible for several hereditary causes of pheochromocytoma. Evaluation of these patients has demonstrated different catecholamine profiles associated with the different syndromes. ...Adrenocortical-sparing …
The last decade has seen the identification of the genes responsible for several hereditary causes of pheochromocytoma. Evalua …
104 results